Δ9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor

被引:67
作者
Downer, E [1 ]
Boland, B [1 ]
Fogarty, M [1 ]
Campbell, V [1 ]
机构
[1] Univ Dublin Trinity Coll, Dept Physiol, Dublin 2, Ireland
关键词
apoptosis; cannabinoid receptor; caspase-3; poly-ADP-ribose polymerase; tetrahydrocannabinol;
D O I
10.1097/00001756-200112210-00024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Delta (9)-Tetrahydrocannabinol, the principal psychoactive component of marijuana, exerts a variety of effects on the CNS, including impaired cognitive function and neurobehavioural deficits. The mechanisms underlying these neuronal responses to tetrahydrocannabinol are unclear but may involve alterations in neuronal viability. Tetrahydrocannabinol has been shown to influence neuronal survival but the role of the cannabinoid receptors in the regulation of neuronal viability hash not been fully clarified. In this study we demonstrate that tetrahydrocannabinol promotes the release of cytochrome c, activates caspase-3, promotes cleavage of the DNA repair enzyme poly-ADP ribose polymerase and induces DNA fragmentation in cultured cortical neurones. These effects of tetrahydrocannabinol were completely abrogated by the CB1 receptor antagonist AM-251. The findings of this study demonstrate that tetrahydrocannabinol induces apoptosis in cortical neurones in a manner involving the CB1 subtype of cannabinoid receptor. NeuroReport 12:3973-3978 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:3973 / 3978
页数:6
相关论文
共 20 条
[1]  
Berrendero F, 1998, DEVELOPMENT, V125, P3179
[2]   EFFECTS OF CHRONIC MARIJUANA USE ON HUMAN COGNITION [J].
BLOCK, RI ;
GHONEIM, MM .
PSYCHOPHARMACOLOGY, 1993, 110 (1-2) :219-228
[3]   Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation [J].
Campbell, VA .
NEUROPHARMACOLOGY, 2001, 40 (05) :702-709
[4]   Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol [J].
Chan, GCK ;
Hinds, TR ;
Impey, S ;
Storm, DR .
JOURNAL OF NEUROSCIENCE, 1998, 18 (14) :5322-5332
[5]  
Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807
[6]   MARIJUANA EFFECT AND DELTA-9-TETRAHYDROCANNABINOL PLASMA-LEVEL [J].
CHIANG, CN ;
BARNETT, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (02) :234-238
[7]   Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action [J].
Di Marzo, V ;
Melck, D ;
Bisogno, T ;
De Petrocellis, L .
TRENDS IN NEUROSCIENCES, 1998, 21 (12) :521-528
[8]   Role of endocannabinoids in brain development [J].
Fernández-Ruiz, JJ ;
Berrendero, F ;
Hernández, ML ;
Romero, J ;
Ramos, JA .
LIFE SCIENCES, 1999, 65 (6-7) :725-736
[9]  
FRIED PA, 1990, J DEV BEHAV PEDIATR, V11, P49
[10]   Anti-tumoral action of cannabinoids:: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation [J].
Galve-Roperh, I ;
Sánchez, C ;
Cortés, ML ;
del Pulgar, TG ;
Izquierdo, M ;
Guzmán, M .
NATURE MEDICINE, 2000, 6 (03) :313-319